JPMorgan Chase & Co. Grows Stock Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY)
JPMorgan Chase & Co. lifted its stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 73.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 31,112 shares of the company’s stock after acquiring an additional 13,190 shares during the period. JPMorgan Chase & Co.’s holdings in ARS Pharmaceuticals were worth $328,000 as of its […]
JPMorgan Chase & Co. lifted its stake in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 73.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 31,112 shares of the company’s stock after acquiring an additional 13,190 shares during the period. JPMorgan Chase & Co.’s holdings in ARS Pharmaceuticals were worth $328,000 as of its […]
